Jones Financial Companies
REGN icon

Jones Financial Companies’s Regeneron Pharmaceuticals REGN Stock Holding History

Jones Financial Companies’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.2M Buy
28,691
+15,928
+125% +$10.8M 0.01% 705
2026
Q1 		$9.42M Buy
12,763
+9,630
+307% +$7.37M ﹤0.01% 846
2025
Q4 		$2.42M Buy
3,133
+641
+26% +$435K ﹤0.01% 876
2025
Q3 		$1.41M Buy
2,492
+584
+31% +$330K ﹤0.01% 1002
2025
Q2 		$994K Buy
1,908
+413
+28% +$231K ﹤0.01% 1009
2025
Q1 		$953K Buy
1,495
+683
+84% +$470K ﹤0.01% 883
2024
Q4 		$578K Buy
812
+421
+108% +$353K ﹤0.01% 942
2024
Q3 		$408K Buy
391
+234
+149% +$260K ﹤0.01% 891
2024
Q2 		$165K Buy
157
+140
+824% +$136K ﹤0.01% 889
2024
Q1 		$16.4K Buy
+17
New +$16.2K ﹤0.01% 946
2023
Q1 		– Sell
-20
Closed -$14K – 742
2022
Q4 		$14K Buy
+20
New +$14.8K ﹤0.01% 453

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Jones Financial Companies's REGN Position: Q2 2026 in Review

Jones Financial Companies increased its Regeneron Pharmaceuticals (REGN) stake by 125% in Q2 2026, buying an estimated $10.8M and bringing the position to 28,691 shares worth $18.2M. The position accounts for 0.01% of the portfolio, ranked #705.

Jones Financial Companies first reported a position in REGN in Q4 2022 and has held it in 11 quarters since. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Jones Financial Companies held 28,691 shares of Regeneron Pharmaceuticals worth $18.2M as of Q2 2026.
  • Jones Financial Companies bought 15,928 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $10.8M.
  • Regeneron Pharmaceuticals made up 0.01% of Jones Financial Companies's portfolio in Q2 2026, its #705 holding.
  • Jones Financial Companies first reported a position in Regeneron Pharmaceuticals in Q4 2022 and has held it in 11 quarters since.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.